However, immunofluorescence staining results showed that the tumours from the fisetin‐treated group have significantly reduced Ki67 positive cell numbers, 5hmC oxygenase TET1 and biomarkers for tumour angiogenesis, CD31 and pVEGFR2 compared with the control group (Figure 3). This evidence concerns the gene MKI67 and neoplasm.